ARCT
Arcturus Therapeutics Holdings Inc
Price:  
13.73 
USD
Volume:  
423,531.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ARCT WACC - Weighted Average Cost of Capital

The WACC of Arcturus Therapeutics Holdings Inc (ARCT) is 7.5%.

The Cost of Equity of Arcturus Therapeutics Holdings Inc (ARCT) is 10.00%.
The Cost of Debt of Arcturus Therapeutics Holdings Inc (ARCT) is 5.00%.

Range Selected
Cost of equity 7.20% - 12.80% 10.00%
Tax rate -% - 2.60% 1.30%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.1% - 8.8% 7.5%
WACC

ARCT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.72 1.42
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 12.80%
Tax rate -% 2.60%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.1% 8.8%
Selected WACC 7.5%